Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes (Q44599736)
scientific article published on October 1, 2003
Language:
(P31) (Q13442814)
(P50) (Q88222602)
(Q96637578)
(P304) 2835-2841
(P407) (Q1860)
(P433) 10
(P478) 26
(P577) Wednesday, October 1, 2003
(P921) (Q3025883)
(Q11180)
(P953) https://care.diabetesjournals.org/content/diacare/26/10/2835.full.pdf
https://diabetesjournals.org/care/article-pdf/26/10/2835/590746/dc1003002835.pdf
(P1433) (Q5270111)
(P1476) "Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes" (language: en)
"Effects of 3 Months of Continuous Subcutaneous Administration of Glucagon-Like Peptide 1 in Elderly Patients With Type 2 Diabetes" (language: en)
(P2093) Nigel Greig
Hugh Tildesley
Dariush Elahi
Graydon S. Meneilly
Joel F. Habener
(P2860) (Q28212600)
(Q42495611)
(Q43781475)
(Q43603840)
(Q43778860)
(Q31835814)
(Q44333581)
(Q43678653)
(Q51613996)
(Q52841240)
(Q47856305)
(Q44244716)
(Q42467547)
(Q27860882)
(Q22250892)
(Q40922729)
(Q73523561)
(Q43687918)
(Q43919658)
(Q51562589)
(Q37377728)
(Q33959262)
(Q44089083)
(Q58448934)
other details
description scientific article published on October 1, 2003

External Links